RIPPLY2
Protein ripply2
Also known as: C6orf159, dJ237I15.1, RIPP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TAB7
- Gene
- RIPPLY2
- Ensembl
- ENSG00000203877
- Chromosome
- 6
- Canonical length
- 128 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a nuclear protein that belongs to a novel family of proteins required for vertebrate somitogenesis. Members of this family have a tetrapeptide WRPW motif that is required for interaction with the transcriptional repressor Groucho and a carboxy-terminal Ripply homology domain/Bowline-DSCR-Ledgerline conserved region required for transcriptional repression. Null mutant mice die soon after birth and display defects in axial skeleton segmentation due to defective somitogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
128 residues, UniProt reviewed canonical sequence.
>Q5TAB7|RIPPLY2
1 MENAGGAEGT ESGAAACAAT DGPTRRAGAD SGYAGFWRPW VDAGGKKEEE TPNHAAEAMP
61 DGPGMTAASG KLYQFRHPVR LFWPKSKCYD YLYQEAEALL KNFPIQATIS FYEDSDSEDE
121 IEDLTCENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RIPPLY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 32 nTPM
- basal ganglia: 24 nTPM
- cerebral cortex: 23 nTPM
- amygdala: 20 nTPM
- hippocampal formation: 19 nTPM
- hypothalamus: 17 nTPM
Single-cell type
- pancreatic islet cells: 19 nCPM
- brain excitatory neurons: 17 nCPM
- retinal ganglion cells: 16 nCPM
- brain inhibitory neurons: 15 nCPM
- other brain neurons: 14 nCPM
- oligodendrocyte progenitor cells: 10 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 20 nTPM
- cerebral cortex: 15 nTPM
- hypothalamus: 13 nTPM
- basal ganglia: 12 nTPM
- hippocampal formation: 11 nTPM
- white matter: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RIPPLY2.
Disease | AllUniProt
Conditions RIPPLY2 is implicated in, by any mechanism.
- Spondylocostal dysostosis 6, autosomal recessive (SCDO6) MIM:616566
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 104 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.56
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone morphogenesis
- determination of left/right symmetry
- embryonic pattern specification
- negative regulation of transcription by RNA polymerase II
- Notch signaling pathway
- ossification
- post-anal tail morphogenesis
- somite rostral/caudal axis specification
- somitogenesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RIPPLY2 as an antibody target. Whether an autoantibody or antibody against RIPPLY2 could matter depends on whether native RIPPLY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RIPPLY2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RIPPLY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...